{"DataElement":{"publicId":"65302","version":"3","preferredName":"Tumor Marker CA-19-9 Test Value","preferredDefinition":"the numeric result for a test sample to evaluate CA 19-9 as an indicator of presence or status of tumor or cancer.","longName":"TMMKR_CA19-9_TST_VAL","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2192294","version":"1","preferredName":"Tumor Marker CA-19-9 Test","preferredDefinition":"information related to a test for tumor marker CA-19-9.","longName":"TMMKR_CA-19-9_TST","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2443094","version":"1","preferredName":"Tumor Marker","preferredDefinition":"A substance sometimes found in an increased amount in the blood, other body fluids, or tissues and which may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (ovarian cancer), CA 15-3 (breast cancer), CEA (ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (prostate cancer). Also called biomarker.","longName":"C17220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A400EF7-3DF6-3538-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-16","endDate":null,"createdBy":"PWEST","dateCreated":"2006-01-16","modifiedBy":"ONEDATA","dateModified":"2006-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207090","version":"3","preferredName":"CA19-9 Antigen Test","preferredDefinition":"CA19-9 is a carbohydrate often found in elevated levels in patients with carcinoma of the pancreas or gastrointestinal tract.:A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"CA19-9","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CA19-9 Antigen","conceptCode":"C327","definition":"CA 19-9 is a fucosylated glycosphingolipid carbohydrate antigen that is soluble and is adsorbed to erythrocytes and to many adenocarcinomas of the digestive tract, especially pancreatic tumors. By structure CA 19-9 is related to the Lewis blood group antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C234BF7-4C07-0FD0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-29","endDate":null,"createdBy":"DWARZEL","dateCreated":"2006-08-29","modifiedBy":"ONEDATA","dateModified":"2006-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E915505A-2B71-0390-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Updated to use fixed NCI Concept for CA19-19 Antigen with correct NCI Thesaurus mapping.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018821","version":"1","preferredName":"Tumor Marker CA-19-9 Test Value","preferredDefinition":"the numeric result for a test sample to evaluate CA 19-9 as an indicator of presence or status of tumor or cancer.","longName":"TMMKR_CA19-9_TST_VAL","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"6","minValue":null,"maxValue":null,"decimalPlace":"1","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184351","version":"1","preferredName":"Value","preferredDefinition":"Value; a numerical quantity measured or assigned or computed.","longName":"Value","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2187-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9E15128-14BE-4D8A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-27","endDate":null,"createdBy":"PWEST","dateCreated":"2003-03-27","modifiedBy":"CAMPBELB","dateModified":"2004-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811964","version":"1","longName":"Tumor Markers","context":"CTEP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104994","version":"1","longName":"RTOG-1201","context":"NRG"},{"publicId":"4171060","version":"1","longName":"RTOG-0848","context":"NRG"}]},{"publicId":"5428034","version":"1","longName":"Clinical","context":"GDC","ClassificationSchemeItems":[{"publicId":"6059563","version":"1","longName":"Followup","context":"GDC"}]},{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"5777527","version":"1","longName":"Pancreatic","context":"OCG"},{"publicId":"6403794","version":"1","longName":"HCC and Bile Duct Cancer","context":"OCG"}]}],"AlternateNames":[{"name":"CA199VAL","type":"OID, SWOG","context":"SWOG"},{"name":"SWOG","type":"USED_BY","context":"SWOG"},{"name":"CA199VAL","type":"Synonym","context":"SWOG"},{"name":"TMMKR_CA19-9_TST_VAL","type":"USED_BY","context":"NRG"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"tumor_marker_CA-19-9_test_value","type":"HCMI Name","context":"OCG"},{"name":"GDC","type":"USED_BY","context":"GDC"},{"name":"ca_19_9_antigen_value","type":"GDC_Name","context":"GDC"}],"ReferenceDocuments":[{"name":"Result of CA 19-9","type":"Preferred Question Text","description":"Result of CA 19-9","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Tumor Marker CA 19-9 Result","url":null,"context":"CTEP"},{"name":"CA 19-9","type":"Alternate Question Text","description":"CA 19-9","url":null,"context":"CTEP"},{"name":"HCMI Question Text","type":"Alternate Question Text","description":"What was the CA-19-9 value?","url":null,"context":"OCG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B9E099F6-CDC2-4D8E-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-27","endDate":null,"createdBy":"PWEST","dateCreated":"2003-03-27","modifiedBy":"COOPERM","dateModified":"2018-08-22","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}